RS

Richard Smith

AC Alberta Research Council: 11 patents #2 of 174Top 2%
BI Bio-Quant: 2 patents #1 of 5Top 20%
T( The Nielsen Company (Us): 2 patents #458 of 768Top 60%
RO Roku: 1 patents #264 of 379Top 70%
CH Chembiomed: 1 patents #8 of 17Top 50%
3C 3Com: 1 patents #653 of 1,190Top 55%
FC Flotek Chemistry: 1 patents #24 of 37Top 65%
📍 Cardiff, WA: #2 of 3 inventorsTop 70%
Overall (All Time): #194,421 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
11184682 Obtaining viewer demographics through advertisement selections 2021-11-23
10934472 Compositions comprising non-halogenated solvents for use in oil and/or gas wells and related methods 2021-03-02
10897657 Obtaining viewer demographics through advertisement selections 2021-01-19
10277958 Obtaining viewer demographics through advertisement selections 2019-04-30
10244772 Method for creating layered chocolate body and chocolate mold for creation thereof 2019-04-02
8731901 Context aware back-transliteration and translation of names and common phrases using web resources Rohini K. Srihari, Erik Petersen 2014-05-20
6245883 Anti-flammatory carbohydrate binding-peptides Louis D. Heerze, Glen D. Armstrong 2001-06-12
6233237 Method and protocol for connecting data calls using R2 signaling Mustafa S. Yucebay, Eric V. Erickson 2001-05-15
6132975 Method of collecting markers of bone metabolism from sweat Paul G. Kanan, Ellen Rudnick 2000-10-17
5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides Louis D. Heerze, Glen D. Armstrong 1998-11-10
5814616 Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen Om Srivastava, Roman Szweda, Robert M. Ippolito, Ulrike D. Spohr 1998-09-29
5747040 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides Louis D. Heerze, Glen D. Armstrong 1998-05-05
5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides Louis D. Heerze, Glen D. Armstrong 1998-04-07
5646123 Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen Robert M. Ippolito, Wasimul Haque, Cong Jiang, H. Rizk Hanna, Andre P. Venot +3 more 1997-07-08
5589346 Method of monitoring markers of bone metabolism Paul G. Kanan, Ellen Rudnick 1996-12-31
5580858 Immunosuppressive and tolerogenic modified Lewis.sup.x compounds Robert M. Ippolito, Wasimul Haque, Cong Jiang, H. Rizk Hanna, Andre P. Venot +2 more 1996-12-03
5571796 Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen Om Srivastava, Roman Szweda, Robert M. Ippolito, Ulrike D. Spohr 1996-11-05
5550155 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures Mohammed A. Kashem, Andre P. Venot 1996-08-27
5453272 Lectin derived carbohydrate binding-peptide Louis D. Heerze, Glen D. Armstrong 1995-09-26
5374655 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures Mohammed A. Kashem, Andre P. Venot 1994-12-20
5043158 Immunogenic compositions containing ordered carriers Uwe Sleytr, Wolfgang Mundt, Paul Messner, Frank Unger 1991-08-27
4923970 Substituted 1-(2-chloroethyl)-3-acyl-3-alkyltriazenes Christopher J. Michejda 1990-05-08